Christopher Amos
Appearances
- DateMay 21, 2024BACKGROUND. Several inflammatory and metabolic biomarkers have been associated with hepatocellular carcinoma (HCC) risk in phase I and II biomarker studies but not in longitudinal studies…
Presenter
Speakers
UT Southwestern Medical CenterBaylor University Medical Center
